chrisvoncsefalvay/vaers-outcomes huggingface dataset:
severe chills; stomach issues; Nausea; tightness; sharp pains in/near shoulder blades; runny nose; she had a little bit of a fever of 101.5F at 4AM. It has dropped to 99.7F and at the time of the call it is 99.6F; This spontaneous case was reported by a patient and describes the occurrence of CHILLS (severe chills), GASTRIC DISORDER (stomach issues), NAUSEA (Nausea), DISCOMFORT (tightness) and ARTHRALGIA (sharp pains in/near shoulder blades) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced CHILLS (severe chills), GASTRIC DISORDER (stomach issues), NAUSEA (Nausea), DISCOMFORT (tightness), ARTHRALGIA (sharp pains in/near shoulder blades), RHINORRHOEA (runny nose) and PYREXIA (she had a little bit of a fever of 101.5F at 4AM. It has dropped to 99.7F and at the time of the call it is 99.6F). At the time of the report, CHILLS (severe chills), GASTRIC DISORDER (stomach issues), NAUSEA (Nausea), DISCOMFORT (tightness), ARTHRALGIA (sharp pains in/near shoulder blades), RHINORRHOEA (runny nose) and PYREXIA (she had a little bit of a fever of 101.5F at 4AM. It has dropped to 99.7F and at the time of the call it is 99.6F) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant  Concomitant product medication was provided by reporter.
felt light headed after injection. Pt admitted not eating all day. felt much better after a can of orange juice.
She has had swelling in the lateral Rt upper arm since at least 18 hrs from the injection. 7-18-17 - mother reported the arm was improving.
rash on her trunk and hair line; This is a spontaneous report from a contactable consumer or other non-hcp. A female patient of an unspecified age received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number was not reported, Expiry date: Unknown) via an unspecified route of administration on 10Feb2021 as dose 1, single for COVID-19 immunisation. The patient medical history included allergic to penicillin from an unknown date and unknown if ongoing. Concomitant medications were not reported. The patient experienced rash on her trunk and hair line on an unspecified date. Therapeutic measures were taken with Prednisone and benadryl as a result of event. The outcome of the event was unknown.  Information about lot/batch number has been requested.  Follow-up (12May2021): Follow-up attempts completed. No further information expected.
doses were given after expiration date; Vaccine placed in refigerator on 21 Sep 2021, vaccine expired on 9 Oct 2021,vaccine administered on 12 Oct 2021; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine placed in refigerator on 21 Sep 2021, vaccine expired on 9 Oct 2021,vaccine administered on 12 Oct 2021) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Oct-2021, the patient experienced PRODUCT STORAGE ERROR (Vaccine placed in refigerator on 21 Sep 2021, vaccine expired on 9 Oct 2021,vaccine administered on 12 Oct 2021). On 12-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine placed in refigerator on 21 Sep 2021, vaccine expired on 9 Oct 2021,vaccine administered on 12 Oct 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  Vaccine was placed in refrigerator was 21 Sep 2021. Patient did not experience any adverse event. No temperature excursion was reported.  No treatment information was provided.
STARTED AT 4PM ON 3/1/2021 WITH CHILLS, GENERALIZED BODY PAIN, FATIGUE, FEVER, LEFT ARM AND AXILLARY PAIN WITH DECREASED RANGE OF MOTION, RIB CAGE PAIN . TOOK TYLENOL
After initial injection there was stiffness in my fingers and soreness  in my left arm that resolved in a couple of days.  A week after injection I had Injection site swelling, redness, and itchiness at the injection site.  Red circle started small and has become larger (approx. 3 inches).  I've used  Cortizone 10 creme a couple times throughout the day to help with itchiness.  I have a previously scheduled doctor's appointment scheduled for 1/18/21 and intend to report and show left arm to Dr.
I had the last shot in early November 07, been sick sense. November 20 Fainted in store multiple times. Perfectly normal healthy happy teenager before.  Have severe pain in stoamche area, had galbladder removed, pain still occured. Have an all over sick feeling. Some days I cant get out of bed.  Had to quit going to highscool after the shot. Have serious stomache and digestive problems. Take medication for IBS which occured after the third Gardail shot. Been to Emergency room over 10 times in the last two years due to ilness and severe pain. 11/2/09:  Vaccine record received, VAERS updated. 11/3/09:  Outpatient Records received for dates of service 11/26/07 to 8/10/09. Dx:  Pelvic pain Assessment:  Long hx. of RUQ and RLQ abdominal pain.  Underwent cholecystectomy with resolution of RUQ pain, but continued to have persistent RLQ pain. Has alternating constipation and diarrhea as well and headaches, blurred vision, dizzy spells and occasional nausea.  Pt. had risk factors for PID so was treated with Rocephin and doxycycline with no relief of sx.  She underwent a diagnostic laparoscopy which was normal.  She is medicated with Lortab for when the pain is most severe.  Her sx. continue.  ICD 9 Codes:  724.2, 789.01, 789.03.  11/13/09 ER recs received for dates 11/20/07 to 6/20/09. DX: viral URI. Presenting SX: cough, nausea, wheezing, abdominal pain x2-3 days. Assessment: WNL.ER visit on 10/25/09 for c/o assault. DX: strain of wrist muscles, shoulder strain, contusion of chest. ER visit 6/2/08 c/o stomach pain, diarrhea. DX: UTI, acute abdominal pain. UA(+)WBC. ER visit on 12/29/07 c/o f/u abdominal pain LUQ pain, epigastric abdominal pain.DX: abdominal pain of undeterm etiology. ER visit 12/15/07 DX:postmononucleosis syndrome, dehydration, presyncope.  Chief c/o vomiting and side pain. Pt. c/o LUQ pain. Pt states have had many episodes off and on. Also c/o dizziness, lightheadedness. PMH: dx w/ mononucleosis weeks prior. US, bloodwork, UA, WNL. ER visit 11/20/07 DX: h/o syncopal episodes, dizziness and nausea resolved. Presented to ER with c/o dizziness, nausea, hives, rt. side flank pain, syncopal episodes, diarrhea. Assessment WNL. Diagnostics WNL.
The patient rapidly developed respiratory failure with oxygen desaturation days after receving the vaccination. Annual follow up states that pt did not recover. Replied to your letter dated 06/26/02 by fax on 07/17/02. Death certificate sent, as requested. Annual follow up on 11/25/03: "It is unknown if the patient recovered from the adverse event." Death Certificate Info: Immediate cause: Pneumonia. Underlying cause: Advanced Dementia. Significant Conditions: Diabetes Follow up on 06/01/2004: states it is unknown if the pt recovered from the adverse event.
This 61yo presents to ER with c/o rash/redness and pain in (L) arm. Pt states he received tetanus and shingles vaccinations both in (L) arm on Monday and noticed symptoms on Tuesday. Pt denies difficulty breathing/swallowing denies rash to any other part of his body. Has had some numbness on ulnar aspect forearm with pain. Diphenhydramine 25 mg prn.
General feeling of being unwell. Exhaustion, loss of taste, loss of smell. Took probably 3 weeks to feel better. I'm not sure my smell and taste have come back fully from where they were before. I don't smell as well as I used to and food does not have as much flavor. Tested positive for COVID.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. On 24-JUN-2015, the patient was vaccinated with improperly stored dose of ROTATEQ oral, lot # K011947, expiration date 07-JUN-2016. No adverse events were reported. This is one of several reprots received from the same source. Additional information has been reuqested.
Pt developed a rash about 1.5 inches wide by 3 inches long at injection site. Area was slightly raised, red, and warm to the touch.
Individual developed a severe headache followed by a bloody nose post-vaccination with second dose.  Individual reports continuing intermittent headaches followed by a bloody nose. She is to follow up with an ENT specialist. Patient also experiencing eye droop of right-side along with facial swelling of that side.
A 66yo female with PMH Arthritis, Pain in joint involving Lt shoulder region, HTN, Migraine, Depressve Disorder, Benign Neoplasm of Cerebral Meninges Per Nurse's documentation Received Pfizer's Covid-19 vaccine First dose March 18, 2021 and second dose on July 8, 2021 per policy and protocol, without any complication However on May 5, 2021 per  telephone documentation, the patient called with CC of adverse reaction to vaccine, had fatigue, dehydration and SOB, went to ER for evaluation. She reported the symptoms lingered for 2 to 4 weeks, had fever, weight loss, chills, and no apetite She was not feeling well since the March 18, Covid-19 vaccube and having dental crown insertion on the same day, at the VA, Also reported she felt worse after day 1 but feeling stronger now and apetite is better
This spontaneous case reported by a nurse, describes the occurrence of administered expired product (vaccine expired April 17, 2022, believed to be administered to 6 people) and product storage error (vaccine stored past expiry date) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 016J212A) for COVID-19 immunization. No medical history reported. On Apr 20, 2022, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 20, 2022, patient administered expired product (vaccine expired April 17, 2022, believed to be administered to 6 people). On an unknown date, patient experienced product storage error (vaccine stored past expiry date). At the time of the report, administered expired product (vaccine expired April 17, 2022, believed to be administered to 6 people) and product storage error (vaccine stored past expiry date) outcome: unknown. The reporter did not provide any causality assessments, concomitant medication or treatment information. The vial did not undergo any temperature excursions. Vial initially stored in the refrigerator on April 1, 2022. This case linked to MOD-2022-545248 (patient link).
Severe flu-like symptoms; Unable to keep down food or water; Disoriented; Severe dehydration; Vomiting; Shivering violently; This is a spontaneous report from a non-contactable consumer or other non hcp (Patient).  A 30-years-old non pregnant female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIOTEH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on an unspecified date as single dose for COVID-19 immunization. Medical history included asthma, depression, allergies to eggplant, kiwi all from an unknown date and unknown if ongoing. Concomitant medication included fluoxetine hydrochloride (PROZAC), bupropion hydrochloride (WELLBUTRIN) both taken for an unspecified indication, start and stop date were not reported. patient previously took amoxicillin and experienced drug hypersensitivity. Historical Vaccine included first dose of bnt162b2 on 31Mar2021 for covid-19 immunization. Patient did not receive other vaccine in four weeks. Patient was not diagnosed with covid prior to vaccination. It was reported that exactly 12 hrs after second shot began severe flu-like symptoms: shivering violently and vomiting. Lasted for approximately 14 hours, severe dehydration, unable to keep down food or water. Moderate flu-like symptoms lasted for 2 days and disoriented for about a week. Adverse event resulted in Doctor or other healthcare professional office/clinic visit. Patient did not receive any treatment for the events. Patient was not tested for covid post vaccination. The outcome for the events was reported as resolved on an unspecified date.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report as received from a registered nurse refers to multiple unspecified patients of unknown age and gender. From 01-JUN-2016 to 23-AUG-2016 the patients were vaccinated with improperly stored ROTATEQ (lot # M005733, Exp 01-OCT-2017, dose unknown) orally, which was exposed at 47 Fahrenheit for 2106 hours and 34 Fahrenheit for 2016 hours. No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Extreme fatigue, body aches, chills, nasal congestion, headache, itchy watery eyes, cough- dry and wet, loss of taste and smell, sinus pain, nasal discharge, diarrhea.  In a 2 month span I went back and forth to the doctor because it was lingering on and on. Dr. prescribed cough medication, antibiotics and pain medication.
Extreme pain in left shoulder, left knee, right wrist,  left leg, left calf, "whole left side" Nausea, Vomiting, chills, sore throat, incontinent;  Currently not ambulatory, "can't eat";  Went to ER Friday (3/19/21), prescribed Morpine and did not help the pain;  RX Tylenol 3 for home - this has not helped. Reports has not seen any other doctor for these health issues.
10/27/2020 Patient reports ever since having flu shot on 9/30/2020 she has had pain in the left arm. She reports it was sore and it now has progressively gotten worse. She feels that pain could be related to immunization. She had a right rotator cuff tear and repair and this feels similar. She denies any pain prior to the shot. She reports she has increased pain with a pulling motions and reaching out. What causes the most pain is reaching overhead. No pain just sitting still. Is slightly tender to press on deltoid at head of the hummerus. She feels pain is muscular in nature. The pain seems to be worsening with activity. No known alternative injury other than immunization. She has been sewing no other activities that include repetitive motion. No radiation of pain. Has not taken any OTC medication. No heat or ice on the area. Patient started on Naproxen delayed release tablet, 500mg, 1 tab(s), orally, 2 times a day, 7 days, 14 tablet, refills 0
No adverse event observed or reported by patient. Vaccine was expired after June 30. 2021.
LOST A LITTLE BIT OF WEIGHT; BOWEL MOVEMENTS HAD BECOME MORE FREQUENT; BOWEL IS VERY LOOSE BATHROOM 7 TIMES BEFORE NOON/DIARRHOEA; This spontaneous report received from a patient concerned a 49 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207AZ1A, and expiry: UNKNOWN) dose was not reported, administered on 25-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 27-MAY-2021, the subject experienced bowel movements had become more frequent. On 27-MAY-2021, the subject experienced bowel is very loose bathroom 7 times before noon/diarrhoea. On an unspecified date, the subject experienced lost a little bit of weight. Laboratory data (dates unspecified) included: Stool culture (NR: not provided) Negative. Treatment medications (dates unspecified) included: bismuth subsalicylate, and loperamide hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from bowel movements had become more frequent, and bowel is very loose bathroom 7 times before noon/diarrhoea, and the outcome of lost a little bit of weight was not reported. This report was non-serious.
Patient got her first dose in March 2021, a month or two after she started having cold like symptoms that quickly turned into muscle weakness and terrible rash all over her body. Patient has tried numerous antibiotics, steroids, creams that have not treated her. . She clearly has dermatomyositis flareup. Rash is barely controlled with 20 mg of prednisone that she stopped taking 4 days ago. She is under care with her rheumatologist and she feels that her blood sugars are starting getting worse again with all the prednisone she was having to take
Diarrhea with gurgling and cramping,  belching, vomiting, tiredness.  Started within a few hours of receiving the vaccine.  Still happening after 42 hours.
could not move her left arm; This case was reported by a physician via call center representative and described the occurrence of mobility decreased in a female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero. On an unknown date, unknown after receiving Bexsero, the patient experienced mobility decreased. On an unknown date, the outcome of the mobility decreased was recovered/resolved.   It was unknown if the reporter considered the mobility decreased to be related to Bexsero.  Additional details were as follows: The age at vaccination was not reported. No patient's identifiers provided. no lot number nor expiration date provided. Physician reported that the female patient received the 1st dose of bexsero and after that patient couldn´t move her left arm for days but she recovered. The reporter did not consent to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020211099:same reporter
Information regarding PREVNAR 13 was received from a nurse regarding an unknown number of patients who experienced very large, warm, bumps or knots at injection site. The patients received a dose on unknown dates in 2010. The patients experienced very large, warm, bumps or knots at injection site in 2010. The reporter commented that she sees this reaction more often when the child or infant is receiving a catch-up dose and the events are usually seen within 2 days after administration of the vaccine. Outcomes are unknown. No additional information was available at the time of this report.
Patient received the vaccine at 11:01am and reported forehead redness at 11:11am. Denies difficulty breathing, throat tightness, mouth tingling, hives/itching, erythema in other areas. Mild diffuse erythema observed on forehead. No erythema spreading to ears, neck, chest. No erythema noted at injection site. Patient in no acute distress.   11:20am BP 138/87, HR 86 11:23am BP 126/102, HR 86, O2 sat 99% Monitored for remainder.  11:30am BP 125/83  11:32am diphenhydramine 25mg PO administered  11:47am BP 131/88, HR 82, O2 sat 99%. Mild forehead erythema without change, no other signs/symptoms.  11:49am patient was discharged home  Approximately 1:15pm called the patient, she reports doing well and feeling better after eating.
first day felt fatigue, arm soreness. took motrin which helped symptoms next day was feeling chills, headache, fatigue. achiness, arm sore, felt hot. took Ibuprofen which helped those symptoms. lasted 4 days. Also during 2nd day felt shortness of breath when talking, taking a deep breath or moving around. Lasted 3 days.
facial swelling; facial numbness; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (facial swelling) and HYPOAESTHESIA (facial numbness) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced SWELLING FACE (facial swelling) and HYPOAESTHESIA (facial numbness). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and TRIAMCINOLONE ACETONIDE at a dose of 0.1 percent. At the time of the report, SWELLING FACE (facial swelling) and HYPOAESTHESIA (facial numbness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product use was reported
Tested positive for Covid-19 on 8/11/2021.  Admitted with acute hypoxic respiratory failure secondary to Covid-19 PNA
At 2 AM patient woke up and her neuropathy was much worse, and symptoms are still present today at 1 PM.
Itchiness around the injection site, followed by a rash.  Soreness around the entire upper left arm.  The symptoms lasted about 3 days.  I applied Cortisone cream on the rash, and it alleviated the itchiness.  Re-applied the cream every few hours until the symptoms subsided.
Increased apneas (severe needing bagging) led to rule out sepsis and antibiotics. Occurred within 24 hours of immunizations. Was near time of discharge.  3/21/08 Reviewed hospital medical records for 01/04-2/22/2008.  Transferred from outlying hospital after birth and transferred from this hospital to another at d/c for continued care. FINAL DX: ex 28 wk preemie twin #1, birth weight 969 gms; recent weight 1680 gms; PMA approx 36 wks; apnea of prematurity; resolved surfactant deficient respiratory distress syndrome; resolved enterobacter pneumonia; immature retins ophthalmology f/u required Records reveal patient experienced presumed sepsis for premature prolonged rupture of membranes.  Developed:retinopathy of prematurity; enterobacter pneumonia; intubated/extubated; continued periods of apnea on caffeine.   4/11/08 Reviewed hospital medical records for 2/22-3/27/2008. FINAL DX: preemie as noted in prior records, anemia, apnea, GERD, PDA ROP, RSV.  Increased severity & frequency of apnea;increased CRP w/n 24 hrs of immunizations & likely due to immunizations in preemies at 2 mo shots. Experienced several apnea spells s/p immunizations, last one 3/19.  Progressed well overall & D/C home on RA, d/c weight 2475 gms, only med iron, taking nipple feeds well on reflux precautions.
Fever of 102.6 bath, tylenol at 7:00 pm child started having seizures, was taken by ambulance to hospital
Information has been received from a medical assistant referring to a 12 years old patient of unknown gender. The patient's concurrent condition, medical history and concomitant therapy were not reported. On 16-JUN-2017, the patient was vaccinated with the first dose of GARDASIL 9 (lot # M036059, expiration date 03-JUN-2019) (dose, route of administration and anatomical location were not reported) for prophylaxis. The administered doses of vaccine was exposed to a temperature excursion between 46.8 degrees Fahrenheit (F) which lasted for a 18 hours and 59 degrees Fahrenheit (F) which lasted for 65 hours on 13-JUN-2017. There was 59F previous temperature excursion for 4 hours. Data logger was used to track the temperature. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1708USA005381: US-009507513-1707USA010591: US-009507513-1709USA012723: US-009507513-1709USA012724: US-009507513-1709USA012725: US-009507513-1709USA012726: US-009507513-1709USA012727: US-009507513-1709USA012728: US-009507513-1709USA012729: US-009507513-1709USA012730: US-009507513-1709USA012731: US-009507513-1709USA012732: US-009507513-1709USA012733: US-009507513-1709USA010537: US-009507513-1709USA012774: US-009507513-1709USA012777: US-009507513-1709USA012776.